$JSECSB - Cashbuild Ltd: Fundamentals Matter More
Cashbuild is still trading far from its all time highs of 2018.
The post-covid-19 crash rally from 7000 to 34599 unfolded in five waves and the correction has been prolonged but contained within a descending channel.
Technically, this calls for further upside and price is currently hovering above the golden ratio 61,8% retracement level.
The fundamental picture looks grim though with Cashbuild having released a trading statement today for the interim results for the 26 weeks ended 25 December 2022.
The company expects;
EPS of between 647.4 cents to 712.1 cents, represents a decrease in EPS of between 45% and 50%;
HEPS of between 678.2 cents to 734.8 cents, represents a decrease in HEPS of between 35% and 40%.
The interim results for the 26 weeks ended 25 December 2022 are expected to be released on or about 1 March 2023.
This should provide a lot more info and hopefully a short-medium term outlook.
Until then, I sit on my hands on Cashbuild.
The post-covid-19 crash rally from 7000 to 34599 unfolded in five waves and the correction has been prolonged but contained within a descending channel.
Technically, this calls for further upside and price is currently hovering above the golden ratio 61,8% retracement level.
The fundamental picture looks grim though with Cashbuild having released a trading statement today for the interim results for the 26 weeks ended 25 December 2022.
The company expects;
EPS of between 647.4 cents to 712.1 cents, represents a decrease in EPS of between 45% and 50%;
HEPS of between 678.2 cents to 734.8 cents, represents a decrease in HEPS of between 35% and 40%.
The interim results for the 26 weeks ended 25 December 2022 are expected to be released on or about 1 March 2023.
This should provide a lot more info and hopefully a short-medium term outlook.
Until then, I sit on my hands on Cashbuild.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.